• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Pertuzumab

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaBiomarker Label Sections with
Pharmacogenomic
Information
PertuzumabOncologyERBB2 (HER2)Indications and Usage
Warnings and Precautions
Adverse Reactions
Clinical Studies
Clinical Pharmacology

 

back to Table of Pharmacogenomic Biomarkers in Drug Labels

-
-